中华放射肿瘤学杂志
Home
|
Journal
|
Editorial
|
Instruction
|
Subscription
|
Advertisement
|
Academic
|
Index-in
|
Contact Us
|
Chinese
中华放射肿瘤学杂志
Office
Journal
Forthcoming Articles
Current Issue
Next Issue
Advanced Search
Archive
Download Articles
Read Articles
Email Alert
RSS
Download
Instruction
Template
Copyright Agreement
More
Quick Search
Advanced Search
Chinese Journal of Radiation Oncology
2017 Vol.26 Issue.2
Published 2017-02-15
Head and Neck Tumors
Thoracic Tumors
Physics·Biology·Technique
Special Feature
Review Articles
Symposium
Special Feature
119
The practice and thinking on the standardized training of radiation oncologic residents
Zhang Ye,Li Yexiong,Wang Lyuhua,Gao Li,Jin Jing,Zhou Zongmei,Wang Shulian,Zhou Caihong,Tang Yu,Deng Lei,Yi Junlin
Radiation oncology is quite different from other medical majors. Without any related courses in undergraduate education, radiation oncology covers many diseases and is difficult for students to learn. Since 2014, radiation oncology has been enrolled into standardized training subjects for resident physicians in China. Therefore, it is quite important to figure out how to perform the standardized training for radiation oncology physicians. Based on the characteristics of radiation oncology, we innovatively introduce mentors, in addition to tutors, to share responsibility for physician training. Resident physicians receive a comprehensive, systematic, and standardized training in terms of clinical practice, clinical thinking, scientific research, and teaching. Meanwhile, a standardized evaluation system is used to assure the effectiveness of the training for resident physicians. This paper preliminarily investigates the problems and corresponding strategies in the standardized training for radiation oncology resident physicians.
2017 Vol. 26 (2): 119-122 [
Abstract
] (
2293
) [
HTML
1KB] [
PDF
935KB] (
0
)
Head and Neck Tumors
123
A clinical study of induction chemotherapy±concurrent chemoradiotherapy for stage N
2-3
M
0
nasopharyngeal carcinoma with plasma Epstein-Barr virus DNA>4000 copies/ml
Chen Junni,Wu Gang,Yang Shipiing,Zhang Shuai,Lin Jie,Wang Fen,Lin Shaoming
Objective
To investigate the value of induction chemotherapy in the treatment of stage N
2-3
M
0
nasopharyngeal carcinoma with plasma Epstein-Barr virus (EBV) DNA>4000 copies/ml.
Methods
A retrospective study was performed on clinical data from 210 patients with stage N
2-3
M
0
nasopharyngeal carcinoma and plasma EBV DNA>4000 copies/ml who were admitted to our hospital from 2009 to 2013. In the 210 patients, 101 received induction chemotherapy plus concurrent chemoradiotherapy (NCRT) and 109 concurrent chemoradiotherapy alone (CCRT). The survival rates were calculated by the Kaplan-Meier method. The log-rank test was used for the analysis of survival rates and univariate analysis of the impacts of the changes in the plasma EBV DNA level after induction chemotherapy on the prognosis.
Results
The 3-year sample size was 154.The NCRT group had significantly higher 3-year disease-free survival (DFS) and distant metastasis-free survival (DMFS) rates than the CCRT group (80.1%
vs.
70.6%, P=0.029;87.1%
vs.
76.0%, P=0.036), while there was no significant difference in 3-year overall survival (OS) rate between the two groups (88.0%
vs.
80.4%, P=0.210). Patients with stage N
2
disease in the NCRT group had significantly higher 3-year DFS and DMFS rates than those in the CCRT group (P=0.031,0.014). Patients with stage N
3
disease in the NCRT group had significantly higher 3-year OS, DFS, and DMFS rates than those in the CCRT group (P=0.029,0.012,0.019). In all the patients, the 3-year OS and DMFS rates were improved with the increase in the cycle number of induction chemotherapy (P=0.020,0.021). In the NCRT group, patients treated with 2, 3, and 4 cycles of induction chemotherapy before radiotherapy had plasma EBV-DNA clearance rates of 51.85%, 76.92%, and 88.57%, respectively (P=0.004). Using the complete clearance of plasma EBV-DNA as a predictor of progression, the sensitivity for the above three groups was 62.50%,66.67% and 75.00(P=0.910), respectively, and the specificity was 57.89%,90.00% and 96.77%(P=0.000), respectively.
Conclusions
In the treatment of nasopharyngeal carcinoma with plasma EBV DNA>4000 copies/ml, induction chemotherapy improves DFS and DMFS in patients with stage N
2-3
M
0
disease and OS in patients with stage N
3
disease;induction chemotherapy dose not improve recurrence-free survival rate. The prognosis and plasma EBV DNA clearance rate are improved with the increase in the cycle number of induction chemotherapy. Using the complete clearance of plasma EBV DNA as a predictor of progression, the sensitivity and specificity in patients treated with 4 cycles of chemotherapy are superior over those in patients treated with 2 or 3 cycles of chemotherapy.
2017 Vol. 26 (2): 123-127 [
Abstract
] (
1308
) [
HTML
1KB] [
PDF
843KB] (
0
)
128
A dose volume analysis of brain stem injury after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma
Yao Chengyun,Wang Lijun,Kong Cheng,Zhang Lanfang,He Xia,Huang Shengfu,Zhang Yiqin
Objective
To investigate the relationship between the incidence of radiation-induced brain stem injury after intensity-modulated radiotherapy (IMRT) and the radiation dose volume in patients with nasopharyngeal carcinoma.
Methods
A retrospective analysis was performed on the data of 258 patients newly diagnosed with nasopharyngeal carcinoma who received IMRT in our group from 2005 to 2013. The radiation dose per unit volume of brain stem was analyzed. The relationship between the incidence of brain stem injury induced by IMRT and the radiation dose volume was studied. The survival rate was calculated using the Kaplan-Meier method. The factors influencing the radiation-induced brain stem injury were analyzed using the Cox regression model.
Results
Two patients with stage T
3
disease and three patients with T
4
disease had radiation-induced brain stem injury. The 3-and 5-year injury incidence rates were 1.6% and 2.4%, respectively. The latency ranged between 9 and 58 months, with a median latency of 19 months. The median D
1%
and D
max
for the brain stem were 54.24 and 59.22 Gy in all patients, 54.31 and 59.45 Gy in patients with stage T
3
disease, and 61.29 and 66.37 Gy in patients with stage T
4
disease, respectively. In the five patients with brain stem injury, the D
1%
and D
max
were larger than 60 and 63 Gy, respectively. The univariate analysis showed that the incidence of radiation-induced brain stem injury was correlated with D
1%
, D
max
, D
0.1 cm
3
, D
0.5 cm
3
, and D
1.0 cm
3
(all P=0.01). The incidence of radiation-induced brain stem injury was significantly lower in patients with D
1%
, D
max
, D
0.1 cm
3
, D
0.5 cm
3
, and D
1.0 cm
3
no larger than 60, 63, 60, 58, and 56 Gy, respectively (all P=0.00).
Conclusions
The incidence of radiation-induced brain stem injury after IMRT is relatively low in patients with nasopharyngeal carcinoma. Strict control of the dose to the brain stem may help to reduce the incidence of brain stem injury and improve the long-term quality of life.
2017 Vol. 26 (2): 128-132 [
Abstract
] (
1768
) [
HTML
1KB] [
PDF
795KB] (
0
)
133
A clinical analysis of radiotherapy combined with temozolomide for postoperative high-grade glioma
Li Kaixin,Kong Yue,Dong Baiqiang,Zhamg Xiaoqian,Hua Yonghong,Shi Lei,Yang Ling,Chen Yuanyuan,Hu Qiaoying,Chen Ming
Objective
To assess the efficacy and safety of three-dimensional radiotherapy (3DRT) combined with temozolomide (TMZ) for postoperative high-grade glioma (HGG), and to explore the prognostic factors for HGG patients.
Methods
A retrospective analysis was performed on the clinical data of 111 patients with postoperative HGG who were admitted to our hospital and received 3DRT combined with TMZ from 2008 to 2015. The efficacy and safety of the treatment were evaluated. The survival rate was calculated by the Kaplan-Meier method and analyzed by the log-rank test. A multivariate prognostic analysis was performed using the Cox model.
Results
The 1-, 2-, and 3-year sample sizes, overall survival (OS) rates, and progression-free survival (PFS) rates were//, 83.5%/46.9%/35.6%, and 52.2%/34.7%/26.4%, respectively. The common adverse reactions during chemoradiotherapy were acute neurotoxicity, hematologic toxicity, hepatotoxicity, and gastrointestinal toxicity, most of which were tolerable. Pathological grade was an independent prognostic factor for OS and PFS rates (P=,).
Conclusions
3DRT combined with TMZ achieves satisfactory efficacy and safety in the treatment of patients with postoperative HGG. Pathological grade is an independent prognostic factor for patients with postoperative HGG.
2017 Vol. 26 (2): 133-137 [
Abstract
] (
1657
) [
HTML
1KB] [
PDF
786KB] (
0
)
Thoracic Tumors
138
Incidence and the high-risk factors of intracranial metastases in the perhippocampus regoin in 345 patients with lung cancer
Chen Dongmei,Meng Xiangying,Shen Ge,Sun Bing,Cong Yang,Liu Chao,Wang Qian,Wang Junliang,Hao Ruimin,Wu Shikai
Objective
To investigate the incidence of and high-risk factors for hippocampal metastasis (HM) in patients with brain metastases of lung cancer, to determine the safety of hippocampus-sparing whole brain radiotherapy (HS-WBRT), and to find out patients eligible for HS-WBRT.
Methods
A retrospective study was performed on clinical data from 345 patients with brain metastases of lung cancer who were admitted to our hospital from 2011 to 2014. The hippocampus plus a 5-mm margin was delineated. Univariate and multivariate logistic analyses were used to identify high-risk factors for hippocampal metastasis. The Cox model was used for multivariate prognostic analysis.
Results
In the 345 patients, there were 1621 intracranial metastatic lesions. Sixteen (4.6%) of the 345 patients and 16(0.99%) of the 1621 intracranial metastatic lesions had hippocampal metastasis;42(12.2%) of the 345 patients and 45(2.78%) of the 1621 intracranial metastatic lesions had metastasis in the hippocampus plus a 5-mm margin. The univariate and multivariate logistic analyses showed that the number of brain metastases was correlated with hippocampal metastasis (HR=1.14,P=0.000). In the 139 patients with intracranial progression after treatment, 17(12.2%) had hippocampal metastasis recurrence. The Cox prognostic analysis showed that tumor stage and genetic information were related to the overall survival in patients with brain metastases.
Conclusions
The number of brain metastases is a high-risk factor for hippocampal metastasis. The lung cancer patients with more brain metastases have a higher incidence of hippocampal metastasis. HS-WBRT is recommended for lung cancer patients with fewer brain metastases, early-stage disease, and genetic mutations or rearrangement.
2017 Vol. 26 (2): 138-143 [
Abstract
] (
1876
) [
HTML
1KB] [
PDF
816KB] (
0
)
144
Association between epidermal growth factor receptor mutation subtypes and the prognosis of brain metastases in patients with lung adenocarcinoma
Zhou Wei,Zhang Jie,Jia Haixia,Cao Jianzhong,Zhang Xiaqin,Song Xin,Li Hongwei
Objective
To explore the association between epidermal growth factor receptor (EGFR) mutation subtypes and the prognosis of brain metastasis in patients with lung adenocarcinoma.
Methods
A retrospective analysis was performed on the clinical data of 256 patients who were admitted to our hospital and confirmed with brain metastases of lung adenocarcinoma by EGFR mutation detection from 2010 to 2015. The prognostic factors for brain metastases were analyzed. The survival rate was calculated by the Kaplan-Meier method and analyzed by the log-rank test. The univariate and multivariate prognostic analyses were performed by the log-rank test and the Cox proportional hazards model.
Results
The median survival time was 10.13 months in all patients. The univariate analysis showed that sex,EGFR mutation status,exon 19 deletion,the Karnofsky Performance Status (KPS) score of brain metastases,and targeted therapy were prognostic predictors (P=0.006,0.001,0.010,0.000,0.003). The multivariate analysis showed that the KPS score and exon 19 deletion were prognostic factors for brain metastases (P=0.000,0.045). When grouped into the recursive partitioning analysis classes,all the patients were split into three subgroups with significantly different prognosis (P=0.000).
Conclusions
Exon 19 deletion is a prognostic predictor of brain metastases in patients with lung adenocarcinoma,which can be integrated into the prognosis scoring system for brain metastases of lung adenocarcinoma. EGFR tyrosine kinase inhibitors improve the survival in patients with brain metastases of lung adenocarcinoma and EGFR mutation,particularly,in those with exon 19 deletion.
2017 Vol. 26 (2): 144-149 [
Abstract
] (
1754
) [
HTML
1KB] [
PDF
832KB] (
0
)
150
A correlation analysis of the changes in plasma level of transforming growth factor beta1 and lymphocyte subset percentages after radiotherapy for patients with lung cancer
Luo Jing,Wei Tingting,Xu Kunpeng,Xu Liming,Gong Linlin,Ren Kai,Wang Xin,Zhao Lujun
Objective
To investigate the relationship between the change in plasma level of transforming growth factor-beta1(TGF-β
1
) after radiotherapy (RT) and short-term treatment outcomes in patients with lung cancer, and to analyze its relationship with the changes in lymphocyte subset percentages in peripheral blood.
Methods
In a prospective study, blood samples before, during, and after treatment were collected from 39 patients with lung cancer who were treated in our hospital from 2014 to 2016. Plasma level of TGF-β
1
was measured by enzyme-linked immunosorbent assay. The percentages of lymphocyte subsets in peripheral blood were determined at each time point. At one month after RT, chest computed tomography was performed to evaluate the short-term treatment outcomes. The response evaluation criteria in solid tumors were used to determine whether there was any response or not.
Results
Patients with lower plasma levels of TGF-β
1
after RT had significantly better short-term treatment outcomes (P<0.05). The changes in plasma level of TGF-β
1
after 2 and 4 weeks of RT and at the end of RT were correlated to the changes in the percentages of CD
4
(+) T and CD
8
(+) T cells and the CD
4
(+)/CD
8
(+) ratio at the same time point (r=-0.581,-0.516,-0.648, P<0.001;r=0.558, 0.545, 0.626, P<0.001;r=-0.615,-0.648,-0.598, P<0.001).
Conclusions
Lung cancer patients with reduced TGF-β
1
levels after RT have better treatment outcomes than those without decreases in TGF-β
1
levels after RT. The mechanism may be related to anti-tumor immunity.
2017 Vol. 26 (2): 150-154 [
Abstract
] (
1754
) [
HTML
1KB] [
PDF
788KB] (
0
)
155
Clinical study of non-operative staging of esophageal squamous cell carcinoma underwent intensity-modulated radiotherapy combined with chemotherapy
Chen Junqiang, Lin Yu, Su Tingfeng,Wang Bingyi,Liu Pingping,Li Jiancheng,Wu Junxin,Pan Jianji,Chen Chuanben
Objective
To compare different non-operative clinical staging criteria regarding their accuracy and feasibility in evaluation of patients with esophageal squamous cell carcinoma (ESCC) receiving concurrent intensity-modulated radiotherapy (IMRT) and chemotherapy.
Methods
A study was performed on clinical data from 242 ESCC patients who received concurrent IMRT and chemotherapy in our hospital from 2008 to 2014. Prognostic prediction was compared between the Chinese 2009 staging system, the 6
th
edition staging system, and a suggested staging system. The survival rates were calculated by the Kaplan-Meier method and analyzed by the log-rank test. A prognostic analysis was made by the Cox model. ResultsThe 3-year sample size and overall survival rate were 168 and 47.4%, respectively. Esophageal tumor volume and the maximum diameter of metastatic lymph nodes were prognostic factors (P=0.000,0.000). An intersection of T
3
and T
4
survival curves was found in the Chinese staging system and the 6
th
version staging system (P=0.696,0.594), while an intersection of N
1
and N
2
survival curves was found in the Chinese staging system (P=0.068). The T staging based on esophageal tumor volume, N staging based on the maximum diameter of metastatic lymph nodes, and their combination could achieve a good separation of survival curves of different stages (P=0.000,0.000,0.000).
Conclusions
The T staging based on esophageal tumor volume combined with the N staging based on the maximum diameter of metastatic lymph nodes is an convenient non-operative clinical staging approach for prognostic prediction of ESCC patients receiving concurrent IMRT and chemotherapy.
2017 Vol. 26 (2): 155-159 [
Abstract
] (
1873
) [
HTML
1KB] [
PDF
879KB] (
0
)
160
Role of radiotherapy in patients with stage Ⅰ—Ⅱ diffuse large B-cell lymphoma of waldeyer’s ring in remission after chemotherapy
Lu Ke,Zhu Yuan,Liu Jianjiang,Liu Peng,Zhang Na,Liu Luying,Luo Jialin,Zhou Ning
Objective
To investigate the impacts of adjuvant radiotherapy on the prognosis of patients with stage Ⅰ—Ⅱ diffuse large B cell lymphoma of Waldeyer’s ring (WR-DLBCL) who achieved complete remission (CR) after chemotherapy.
Methods
Clinical data were collected from 130 patients with stage Ⅰ—Ⅱ WR-DLBCL who were admitted to our hospital from 2005 and 2013. All the patients achieved CR after at least two cycles of cyclophosphamide,doxorubicin/epirubicin,vincristine,and prednisone (CHOP)-based chemotherapy or rituximab plus CHOP (R-CHOP)-based chemotherapy. In the 130 patients,43 received R-CHOP (including 25 patients undergoing radiotherapy) and 87 CHOP (including 76 patients undergoing radiotherapy);29 received chemotherapy alone and 101 chemoradiotherapy. The survival rates were calculated by the Kaplan-Meier method and analyzed by the log-rank test. Univariate and multivariate prognostic analyses were made by the log-rank test and the Cox model,respectively.
Results
In all patients,the 5-year sample size was 101. The univariate analysis showed that patients with an Eastern Cooperative Oncology Group (ECOG) score of 0 had significantly higher 5-year overall survival (OS) and disease-free survival (DFS) rates than those with an ECOG score of 1(95.6%
vs.
80.1%,P=0.000;95.7%
vs.
75.4%,P=0.029). Patients treated with chemotherapy alone had significantly lower 5-year OS and DFS rates than those treated with chemoradiotherapy (77.1%
vs.
91.7%,P=0.048;77%
vs.
87.4%,P=0.037). The multivariate analysis by the Cox model showed that ECOG score was a prognostic factor for both OS and DFS (P=0.047,0.003). Adjuvant radiotherapy was related to improved DFS rather than OS (P=0.039,0.133).
Conclusions
Stage Ⅰ—Ⅱ WR-DLBCL patients with low ECOG scores have better prognosis than those with high ECOG scores. Patients with CR after chemotherapy may benefit from adjuvant radiotherapy. The conclusions need to be further confirmed by prospective randomized controlled trials.
2017 Vol. 26 (2): 160-164 [
Abstract
] (
2352
) [
HTML
1KB] [
PDF
814KB] (
0
)
165
Feasibility of placing a dose constraint to peritoneal space instead of bowel loop in protection of the small intestine during intensity-modulated radiotherapy for rectal cancer
Qian Jianjun,Sun Yanze,Yang Yongqiang,Chen Liesong,Tian Ye
Objective
To compare the dose volume and normal tissue complication probability (NTCP) of small intestine between intensity-modulated radiotherapy (IMRT) with dose constraints to the peritoneal space (PS) and the bowel loop (BL) in the treatment of rectal cancer, and to investigate the feasibility of placing a dose constraint to the PS instead of the BL in protection of the small intestine.
Methods
A total of 24 patients with rectal cancer undergoing postoperative adjuvant radiotherapy were enrolled as subjects. In the 24 patients, 12 were treated in supine position and 12 in prone position. The weekly computed tomography (CT) scans from pre-treatment to weeks 1-4 of treatment were defined as Plan, 1 W, 2 W, 3 W, and 4 W. Contours of PS and BL were delineated on all CT images. Based on the Plan CT images, two IMRT plans, P
PS
and P
BL
, were designed with dose constraints to the PS and BL, respectively. The method was applied to 1-4 W CT images. For each CT scan, the dose volume and NTCP of the small intestine were evaluated in P
PS
and P
BL
.
Results
A total of 109 sets of CT images were acquired from 24 patients, and 218 plans were designed and copied. The median volume of the PS and BL was 1339.28 and 250.27 cm
3
, respectively. For the Plan CT scans, V
15
values of the PS in P
PS
plan and the BL in P
BL
plan were 918.96 and 199.57 cm
3
, respectively. For all CT scans, the dose volume of the small intestine in P
PS
, in most cases, was lower than that in P
BL
, while V
15
values in P
PS
and P
BL
were 170.07 and 178.58 cm
3
(P=0.000). The dose volume of the small intestine was correlated with V
15
(P=0.000). P
PS
had significantly lower NTCP of chronic and acute adverse reactions than P
BL
(2.80%
vs.
3.00%, P=0.018;57.32%
vs.
58.64%, P=0.000). In patients with prone and supine treatment positions, most of the dose volume and NTCP of the small intestine in P
PS
were significantly lower than those in P
BL
(P<0.05 for V
10
, V
15
, V
30
, and NTCP of acute adverse reactions).
Conclusions
It is feasible to place a dose constraint to the PS instead of the BL for protection of the small intestine during IMRT for rectal cancer. V
15
<830 cm
3
can be referred to as the objective function of dose restraint.
2017 Vol. 26 (2): 165-170 [
Abstract
] (
1721
) [
HTML
1KB] [
PDF
1170KB] (
0
)
171
Effect of independent breath-holding technology on target geometry in radiotherapy for liver cancer
Hong Chaoshan,Zhu Xiaodong,Qu Song,Qing Liping,Fu Qingguo,Deng Ye
Objective
To use the fusion image of the end-inhalation holding (EIH) phase and end-exhalation holding (EEH) phase to define the target volume of individual patient with liver cancer, and to evaluate the target geometry, feasibility, and clinical significance of the technology.
Methods
Eighteen patients with liver cancer who were treated in our hospital from 2012 to 2013 were enrolled as subjects. With the same posture and scan range, all patients underwent contrast-enhanced three-dimensional computed tomography (3DCT) scans in the phases of free breathing (FB), EIH, and EEH. Gross tumor volume (GTV), clinical target volume (CTV), and organ of risk (OAR) were delineated on the above images. CTV
FB
was defined as GTV on the FB phase image (GTV
FB
) plus a margin of 10 mm, while planning target volume (PTV
FB
) was defined as CTV
FB
plus a margin of 10 mm in the right-left and anterior-posterior directions and a margin of 20 mm in the superior-inferior direction. GTV
EI
and GTV
EE
were defined as GTV on the EIH and EEH images, respectively. Based on the EEH images, the registered EEH and EIH images were fused to form GTV
EI+EI
. CTV
EI+EE
was defined as GTV
EI+EI
plus a margin of 10 mm, while PTV
EI+EE
was defined as CTV
EI+EE
plus a margin of 5 mm in the right-left and anterior-posterior directions and a margin of 10 mm in the superior-inferior direction. The Pinnacle
3
v8.0m treatment planning system was used to design two 3D conformal radiotherapy plans for each patient. The volume, degree of inclusion (DI), matching index (MI), and central displacement of CTV
FB
and CTV
EI+EE
, as well as PTV
FB
and PTV
EI+EE
, were compared between the two plans.
Results
In the 18 patients, the mean CTV
FB
was significantly smaller than the mean CTV
EI+EE
(149.00±87.54 cm
3
vs.
188.17±125.72 cm
3
, P=0.014);there was no significant difference between the mean PTV
FB
and PTV
EI+EE
(276.68±146.41 cm
3
vs.
253.66±117.35 cm
3
, P=0.080). DI of CTV
FB
to CTV
EI+EE
, PTV
FB
to PTV
EI+EE
, CTV
EI+EE
to CTV
FB
, and PTV
EI+EE
to PTV
FB
were (99.83±0.09)%,(84.55±8.45)%,(80.83±12.31)%, and (99.78±0.08)%, respectively. MI of CTV
EI+EE
to CTV
FB
and PTV
EI+EE
to PTV
FB
were 0.83±0.07 and 0.87±0.03, respectively. The central displacements of CTV
EI+EE
from CTV
FB
in x, y, and z axes were 0.55±1.07 cm, 0.76±3.02 cm, and -0.26±1.98 cm, respectively (P=0.432, 0.971, 0.587).
Conclusions
In the treatment of liver cancer, the target volume delineation and image fusion using 3DCT images in EIH and EEH phases may avoid target omission due to respiratory movement, making it possible to increase radiation dose to target volume and improve the efficacy of radiotherapy.
2017 Vol. 26 (2): 171-177 [
Abstract
] (
1887
) [
HTML
1KB] [
PDF
917KB] (
0
)
Physics·Biology·Technique
178
Knowledge-based semi-automated optimization of intensity-modulated radiotherapy plans using a volume modulated arc therapy-configured model
Zhang Yibao,Jiang Fan,Yue Haizhen,Hu Qiaoqiao,Zhang Jian,Gong Jian,Wu Hao
Objective
To evaluate the feasibility and dosimetric features of a volume modulated arc therapy (VMAT)-configured model in knowledge-based optimization of fixed-field dynamic intensity-modulated radiotherapy (IMRT) plans based on the Varian RapidPlan system.
Methods
① A dose-volume histogram prediction model was trained with 81 qualified preoperative VMAT plans for rectal cancer and then statistically verified. ② For clinically approved 10 IMRT plans with the same dose prescription, the above model was used to automatically generate new optimization parameters and dynamic multileaf collimator (MLC) sequences with field geometry and beam energy unchanged. ③ In order to rule out the disparities between different versions, a single algorithm was used to calculate the absolute doses of the original and new plans. ④ Statistical analyses were performed on dosimetric parameters after comparable target dose coverage was achieved in the two plans by appropriate normalization.
Results
On the basis of similar target dose homogeneity and coverage, RapidPlan significantly reduced the doses to the urinary bladder (D
50%
by 9.01 Gy, P=0.000;D
mean
by 8.08 Gy, P=0.005) and the femoral head (D
50%
by 4.20 Gy, P=0.000;D
mean
by 3.84 Gy, P=0.005) but significantly elevated the mean total number of monitor units (1211±99
vs.
771±79, P=0.000) and the number of fields with multiple MLC carriage groups. The knowledge-based semi-automated optimization caused a significantly larger number of high-dose hotspots but a similar D
2%
(52.54
vs.
52.71 Gy, P=0.239).
Conclusions
The VMAT model can be used for the knowledge-based semi-automated optimization of IMRT plans to enhance the efficiency and OAR protection. However, the resulting high-dose hotspots need further manual intervention.
2017 Vol. 26 (2): 178-181 [
Abstract
] (
1964
) [
HTML
1KB] [
PDF
792KB] (
0
)
182
Effect of leaf movement speed on setup error of multileaf collimator in volumetric modulated arc therapy mode
Wang Guangshan,Yang Bo,Pang Tingtian,Sun Xiansong,Qiu Jie
Objective
To study the effect of leaf movement speed on the setup error of multileaf collimator (MLC) in RapidArc mode, and to improve quality assurance and verify the reliability of RapidArc.
Methods
Referring to the PicketFenceStatic_M120.dcm and PicketFenceRA_M120.dcm files, the Tilt tests with different adjacent leaf speed were designed and setup errors of MLC were obtained by analyzing electronic portal imaging device images.
Results
In the Tilt tests, the setup errors gradually increased from gap11 to gap50 in both static gantry mode and RapidArc mode. With a gantry angle of 270°, gap41 had the maximum setup error of -0.55 mm. In the RapidArc mode, gap46 had the maximum setup error of -0.67 mm. The deviation of gap width was no greater than 15% in any mode. There was no significant difference in deviation pattern of gap width between four modes with different gantry angles. The same gaps in different stripes showed a consistent trend in gap width. The RapidArc mode had a larger variation in percentage deviation of gap width than the static gantry mode.
Conclusions
The setup error increases with the increase in the speed of MLC leaf. The variation in the leaf speed has no significant impact on the gap width. There is no correlation between the leaf speed and the deviation of gap width. Four different gantry angles give similar deviation patterns of gap width, suggesting that the deviation of gap width is related to the leaf rather than the gantry angle. The RapidArc mode has a greater impact on the gap width than the fixed gantry mode.
2017 Vol. 26 (2): 182-186 [
Abstract
] (
1932
) [
HTML
1KB] [
PDF
1014KB] (
0
)
187
Relationship between the overlap volume of organ at risk and target and the dose to organ at risk in intensity-modulated radiotherapy
Pang Haowen,Sun Xiaoyang,Yang Bo,Shi Xiangxiang,Tang Tao,Wu Jingbo
Objective
To explore the relationship between the overlap volume of organ at risk (OAR) and target (V
overlap
) and the mean dose to OAR (D
mOAR
) in intensity-modulated radiotherapy (IMRT).
Methods
Fifty randomly selected patients undergoing IMRT for nasopharyngeal carcinoma (NPC) and an equal number of patients undergoing radical IMRT for cervical cancer in our hospital were enrolled as subjects. The relationship between V
overlap
and D
mOAR
in IMRT was analyzed. The Matlab software was used to generate function to fit the relationship between V
overlap
and D
mOAR
for different OARs.
Results
The V
overlap
varied among patients with NPC or cervical cancer. The ratio of V
overlap
to the volume of OAR (V
OAR
) was positively correlated with the ratio of D
mOAR
to the prescribed dose (D
p
)(all P=0.01). A function was generated to fit the correlation between V
overlap
/V
OAR
ratio and D
mOAR
/D
p
ratio.
Conclusions
In IMRT, patients have different V
overlap
/V
OAR
ratios due to varied target volume, disease stages, OAR filling status, and OAR volume. As criteria for plan verification, a specific D
mOAR
value for each OAR should be calculated before radiotherapy planning based on the corresponding correlation function and the V
overlap
/V
OAR
ratio with a fixed dose prescription. It can be used to reduce the subjective influence on the optimization of radiotherapy planning.
2017 Vol. 26 (2): 187-191 [
Abstract
] (
1850
) [
HTML
1KB] [
PDF
912KB] (
0
)
192
Observation of CT-MRI image fusion in postoperativeprecise radiotherapy for gliomas
Huang Rong,Wu Hui,Lu Xiaoxu,Xu Jing,Wang Yanling,Li Dingjie,Cheng Zhiyao
Objective
To investigate the value of computed tomography (CT)-magnetic resonance imaging (MRI) image fusion in target volume delineation of postoperative precise radiotherapy for gliomas.
Methods
Thirty-six patients newly diagnosed with gliomas were enrolled and received postoperative intensity-modulated radiotherapy. Landmark (L) combined with manual fusion (M) and maximization of mutual information (MI) was used for image fusion. Target volume and organs at risk were delineated based on CT images and fused images, respectively. Comparison of the volume was made by pairwise t test. The distance from a landmark on CT image to the corresponding one on MRI image was calculated. The volume method and geometric center method were used to calculate the degree of volume overlap and changes in central positions after image fusion.
Results
The L+M+MI method achieved a high registration accuracy in image fusion, with a registration error less than 2 mm. In patients with grade Ⅲ-IV gliomas, the CT images yielded significantly smaller gross tumor volume (GTV) and clinical target volume (CTV) than the MRI images (74.62±46.91
vs.
105.99±58.86 cm
3
, P=0.042;304.03±130.05
vs.
387.94±150.12 cm
3
, P=0.040). After image fusion, the smallest change in central position occurred in the chiasma (1.32±1.42 mm), and the largest change occurred in CTV (7.99±11.06 mm), followed by GTV and the brain stem.
Conclusions
CT-MRI image fusion helps to reduce the uncertainty of target volume delineation in patients with gliomas, especially in those with edema and residual tumor after surgery.
2017 Vol. 26 (2): 192-196 [
Abstract
] (
1831
) [
HTML
1KB] [
PDF
916KB] (
0
)
197
Commission of volumetric modulated arc therapy with electronic portal image device
Ma Yangguang,Pei Yuntong,Mai Rizhen,Hu Jinyan,Liu Shuaipeng,Jia Fei,Wang Tao,Liu Lele,Guo Yuexin
Objective
To apply electronic portal imaging device (EPID) in the quality assurance of volumetric modulated arc therapy (VMAT) delivered by TrueBeam linear accelerator.
Methods
The Shaper software and Eclipse treatment planning system (TPS) were used to edit the VMAT plan delivered by TrueBeam linear accelerator. The EPID was used to evaluate the setup accuracy of multi-leaf collimator (MLC) and clinical dosimetry. TA:a field with a size of 0.5 cm×20.0 cm was exposed with gantry angles of 0°, 90°, and 270°, respectively;TB:the flatness and stability of the field were tested with different combinations of dose rate and gantry angle speed;TC:the setup accuracy of MLC was evaluated with or without rotation;TD:the accuracy of speed change control of MLC was evaluated with or without rotation;TE:the accuracy of simultaneous changes in dose rate and gantry angle speed was evaluated;TF:Clinical patients were evaluated. The Matlab software was used to analyze the results.
Results
TA:the full width at half maximum of superimposed fields exposed with gantry angles of 0°, 90°, and 270°was 0.39 mm larger than that of the field exposed with a gantry angle of 0°. TB:the difference in flatness was less than 0.5% between fields with different combinations of dose rate and gantry angle speed. TC:the maximum difference in field center was 0.45 mm between EPID measurement and TPS setting. TD:the maximum difference in MLC position was 0.69 mm between EPID measurement and TPS setting. TE:the maximum difference was 0.42 mm between fields. TF:for all the patients, the lowest γ passing rate was 96.4% according to the criterion of 3%/3 mm.
Conclusions
EPID is an accurate and convenient approach for VMAT quality assurance, which provides an option for physicists to reduce workload.
2017 Vol. 26 (2): 197-201 [
Abstract
] (
1908
) [
HTML
1KB] [
PDF
954KB] (
0
)
202
Dosimetric characterization of a novel dual-energy medical linear accelerator without a flattening filter
Yang Xin,Sun Wenzhao,Chen Li,Luo Guangwen,Lin Mao-sheng,Huang Xiao-yan
Objective
To study the dosimetric characteristics of flattened and flattening filter free (FFF) beams with 6 MV and 10 MV photon energy using a novel dual-energy medical linear accelerator (Elekta Versa HDTM), to identify the dosimetric characteristics and advantages of FFF beams, and to provide a basis for their clinical application.
Methods
The percentage depth dose (PDD), profiles/dose rate of off-axis ratio (OAR), field size, penumbral width, dose out of the fields, collimator scatter factor (S
c
), and total scatter factor (S
c,p
) were compared between flattened and FFF beams.
Results
(1) After beam energy matching, the FFF beams had the same beam energy with the flattened beams. The matching error of PDD at a depth of 10 cm was less than 1% between fields.(2) The FFF beams had a smaller variation in dose rate of OAR with the depth than the flattened beams.(3) The FFF beams had smaller variations in field size and penumbral width than the flattened beams. Moreover, the penumbral width of the FFF beams increased with the increasing field size or depth. The FFF beams had a lower dose out of the fields than the flattened beams.(4) The FFF beams had smaller variations in S
c
and S
c,p
with the field size and depth than the flattened beams.
Conclusions
Removal of the flattening filter can substantially improve the dose rate, shorten radiotherapy time, and reduce leakage and scattering of the head. The dosimetric advantages make the FFF beams appropriate for clinical treatment.
2017 Vol. 26 (2): 202-209 [
Abstract
] (
1847
) [
HTML
1KB] [
PDF
0KB] (
0
)
210
Application of new three-dimensional printed tissue compensators in radiotherapy
Zhang Min,Zhao Bo,Yin Jinpeng,Liu Siwei,Gao Xianshu,Qin Shangbin,Wang Qingguo,Zhao Qing,Liu Ling,Li Xiaomei,Li Hongzhen,Li Xiaoying,Ma Mingwei
Objective
To develop three-dimensional (3D) printed tissue compensators for irregular body surface in radiotherapy.
Methods
Pre-clinical evaluation was made among human phantoms with no tissue compensators, commercially available tissue equivalent bolus, and 3D printed tissue compensators. Perineal computed tomography (CT) images were acquired from the above three human phantoms with the same prescription dose to the same target volume (D
95%
=100 cGy). Intensity-modulated radiotherapy plans for the three human phantoms were designed using the same treatment planning system. The dosimetric parameters of planning target volume (PTV) were compared between the three plans. The dosimetric parameters were evaluated among 10 patients who were treated with 3D printed tissue compensators.
Results
The electron density of the selected material was 1.00-1.01. The phantoms with no tissue compensators, commercially available tissue equivalent bolus, and 3D printed tissue compensators had D
max
of 182.9, 118.9, and 114.8 cGy, D
mean
of 146.2, 107.7, and 104.1 cGy, and homogeneity index (HI) of 0.565, 0.15, and 0.11 for PTV, respectively. All the 10 patients had highly personalized 3D printed tissue compensators with satisfactory dose homogeneity (HI=0.03-0.15 with a median of 0.06). Five patients with Paget′s disease of penis and scrotum benefited from the support and fixation by 3D printed tissue compensators.
Conclusions
The highly personalized 3D printed tissue compensators can provide a positioning support for patients and effectively increase the dose to the skin.
2017 Vol. 26 (2): 210-214 [
Abstract
] (
1587
) [
HTML
1KB] [
PDF
903KB] (
0
)
215
Gene expression profiling of a radioresistant esophageal squamous cancer cell line
Zhou Lingran,Bai Lu,Wang Liang,Cheng Min,Qian Liting
Objective
To establish a radioresistant esophageal squamous cancer cell line, and to identify the radioresistant genes and mechanisms.
Methods
The radioresistant KYSE410-res cell line was established by repeated exposure of cell line KYSE410 to radiation. The proliferation and apoptosis of esophageal squamous cancer cells were evaluated before and after radiation. The changes in gene expression of the esophageal squamous cancer cells after radiation were determined by gene microarray and analyzed by group t test. The genes with significant difference in expression after radiation were validated.
Results
The KYSE410-res cells had significantly enhanced proliferation and anti-apoptosis than the KYSE410 cells (all P<0.05). The result of gene microarray showed that compared with the KYSE410 cells, the KYSE410-res cells had the expression of 463 and 251 genes upregulated and downregulated by no less than 4 folds, respectively. Those genes with different expression levels after radiation were mainly responsible for cell proliferation, adhesion, signal transduction, angiogenesis, reactive oxygen metabolism, cell damage repair, and the MAPK/ERK signaling pathway. OAS2 and UBD were key proteins in the network. In the KYSE410-res cells, the expression of HLA-DQB1, MMP1, NCAM
1
, ZNF521, GPC6, SELENBP1, LCN15, and TFPI-2 genes measured by real-time PCR was consistent with that measured by gene microarray.
Conclusions
Abnormal activation of the MAPK/ERK signaling pathway, upregulated expression of OAS2 and UBD, downregulated expression of TFPI-2, and upregulated expression of MMPs may play a role in radioresistance of esophageal cancer cells.
2017 Vol. 26 (2): 215-221 [
Abstract
] (
1820
) [
HTML
1KB] [
PDF
945KB] (
0
)
222
Pretreatment with chronic intermittent hypobaric hypoxia attenuates radiation-induced heart damage in rats
Wu Yajing,Wang Jun,Wang Yuan,Wang Sheng,Liu Qing,Wang Yi,Cao Feng,Cheng Yunjie,Jiao Wenpeng
Objective
To study cardioprotective effects of pretreatment with chronic intermittent hypobaric hypoxia (CIHH) on acute radiation-induced heart damage, and to explore the potential mechanisms.
Methods
Forty-eight male adult Sprague-Dawley rats were randomly divided into control group, CIHH group, radiation group, and CIHH+radiation group. Pretreatment with CIHH was performed by placing rats in a hypobaric chamber before radiation. Left ventricular function was recorded and myocardial infarction area was determined. Collagen volume fraction (CVF) was calculated after Masson staining. The activity of total superoxide dismutase (T-SOD) and content of lipid peroxide malondialdehyde (MDA) were determined by enzyme linked immunosorbent assay. The expression levels of a marker of fibrosis, collagen type I (COL-1), and two markers of endoplasmic reticulum stress, GRP78 and CHOP, were analyzed by Western blot. Difference test using two factor analysis of variance.
Results
Compared with the radiation group, the CIHH+radiation group had improved left ventricular systolic and diastolic function and reduced myocardial infarction area;the CIHH+radiation group also had significantly reduced CVF, significantly lower expression of COL-1, significantly higher activity of T-SOD, significantly lower concentration of MDA, and significantly lower expression levels of GRP78 and CHOP (P<0.01,P<0.01;(185.19±3.20)
vs.
(156.61±4.60) U/mgprot, P<0.01;(1.36±0.17)
vs.
(2.36±0.21) nmol/mgprot, P<0.01;P<0.05;P<0.01).
Conclusions
Pretreatment with CIHH can to a certain degree reduce radiation-induced damage to the cardiac coronary artery, enhance cardiac tolerance to ischemia/reperfusion injury, reduce myocardial infarction area after ischemia/reperfusion, and improve collagen deposition in perivascular region and myocardial stroma. CIHH protects myocardium probably via inhibition of oxidative stress, endoplasmic reticulum stress, and myocardial fibrosis.
2017 Vol. 26 (2): 222-227 [
Abstract
] (
1657
) [
HTML
1KB] [
PDF
1230KB] (
0
)
228
A study of radiation injury in rat C6 glioma cell line by
1
H-nuclear magnetic resonance spectroscopy
Li Hongxia,Cui Yi,Xu Yanjie,Li Fuyan,Shi Wenqi,Wang Jianzhen,Zeng Qingshi
Objective
To study the radiation injury of rat C6 glioma cell line by high resolution,
1
H-nuclear magnetic resonance (
1
H NMR) spectroscopy, and to preliminarily investigate its mechanism.
Methods
Metabolite concentrations in C6 cells were determined by
1
H NMR spectroscopy. Comet assay was used to evaluate DNA damage. Flow cytometry was used to determine the cell cycle and apoptosis rate. Colony-forming assay was used to measure the colony-forming rate and preliminarily investigate the mechanism of radiation injury. The results were analyzed by one-way analysis of variance and Pearson correlation analysis.
Results
With the increase in radiation dose from 0 Gy to 1, 5, 10, and 15 Gy, DNA damage was enhanced in a dose-dependent manner (P=0.000-0.690);the percentage of cells in G
1
phase increased (P=0.026-0.749);the apoptosis rate significantly increased (all P=0.000);the colony-forming rate significantly declined (P=0.000-0.004);the Lac/Cr ratio significantly decreased (P=0.000-0.015), which had a negative linear correlation with DNA damage parameters (tail length,
r
=-0.971;%DNA in the tail,
r
=-0.998;tail moment,
r
=-0.995) and apoptosis rate (
r
=0.978).
Conclusions
1
H NMR spectroscopy reveals that the change in the Lac/Cr ratio is associated with injury and apoptosis of C6 cells after radiation.
1
H NMR spectroscopy has the potential to predict radiation injury of glioma.
2017 Vol. 26 (2): 228-233 [
Abstract
] (
1667
) [
HTML
1KB] [
PDF
1133KB] (
0
)
Review Articles
234
Research advances in stereotactic body radiation therapy for primary liver cancer
Tong Jinlong,Zheng Qin,Sun Xinchen
Stereotactic body radiation therapy (SBRT) adopts different tumor-killing mechanisms from the conventional fractionated radiotherapy. In SBRT, a single high-dose radiation can destroy the membrane of tumor cells and induce the release of tumor-associated antigen, also named in situ tumor vaccine, which stimulates the immune system to kill the residual tumor;a single-fraction radiation with a dose larger than 8-10 Gy can induce rapid apoptosis of vascular endothelial cells via the acid sphingomyelinase pathway at 1-6 hours after radiation, which causes tumor vascular occlusion and secondary tumor-killing effects. In order to understand whether SBRT improves the clinical treatment outcomes via the above mechanisms, this paper reviews the clinical research advances in SBRT for primary liver cancer.
2017 Vol. 26 (2): 234-238 [
Abstract
] (
1875
) [
HTML
1KB] [
PDF
811KB] (
0
)
239
Application of diffusion-weighted magnetic resonance imaging in radiotherapy for esophageal carcinoma
Li Guanghu,Qian Liting
As an important component of functional magnetic resonance imaging, diffusion-weighted magnetic resonance imaging (DWI) can provide qualitative and quantitative information for tumor evaluation and distinguish esophageal lesions and mediastinal lymph node metastasis. DWI-computed tomography fusion images facilitate the delineation of target volume. During radiotherapy or concurrent chemoradiotherapy for esophageal carcinoma, monitoring the changes in apparent diffusion coefficient value helps to predict the early treatment outcomes and prognosis;DWI compensates for the shortcomings of radiography alone in the evaluation of short-term treatment outcomes. This paper reviews the application of DWI in the diagnosis, delineation of target volume, assessment of treatment outcomes, and prognostic prediction in radiotherapy for esophageal carcinoma.
2017 Vol. 26 (2): 239-242 [
Abstract
] (
1655
) [
HTML
1KB] [
PDF
782KB] (
0
)
243
Early evaluation of tumor radiation response by medical imaging
Zhang Nasha,Zhu Hui,Zhu Jian,Yu Jinming
Response evaluation criteria in solid tumors is widely used for assessing tumor response to radiotherapy in clinical practice. However, it is clearly insufficient. Currently there is no ideal method for early evaluation of tumor radiation response. This paper reviews studies on early evaluation of radiotherapy efficacy by positron emission tomography-computed tomography (CT), magnetic resonance imaging, and CT. This paper also further explores the necessity and feasibility of CT values of megavoltage CT scans in early evaluation of the radiosensitivity of tumor during tomotherapy.
2017 Vol. 26 (2): 243-246 [
Abstract
] (
1823
) [
HTML
1KB] [
PDF
774KB] (
0
)
Symposium
247
Application of small animal radiation research platform in radiotherapy
Zhang Yanjun,Deng Yun,Xu Qing,Zhang Zhen
Small Animal Radiation Research Platform (SARRP) is a highly efficient platform specifically designed for research in the fields of radiation oncology and radiobiology. This platform possesses precise radiometers with gantries capable of isocentric, coplanar, and non-coplanar conformal irradiation. Based on the three-dimensional images acquired by the cone-beam computed tomography, the platform can perform “real time” treatment planning and irradiation, which assures timeliness for precise irradiation and research on small animals. The wide application of SARRP not only accelerates the bench to bedside translation, but also facilitates the development of radiation oncology and radiobiology.
2017 Vol. 26 (2): 247-249 [
Abstract
] (
1526
) [
HTML
1KB] [
PDF
882KB] (
0
)
250
2017 Vol. 26 (2): 250-250 [
Abstract
] (
1122
) [
HTML
1KB] [
PDF
859KB] (
0
)
中华放射肿瘤学杂志
News
·
·
More
.....
Cooperation unit
友 情 链 接
China Association for
Science and Technology
Chinese Medical Association
Cancer Hospital of Chinese
Academy of Medical
Sciences Department of
Radiation Oncology
Chinese Anti-Cancer
Association
Chinese Journal of Lung
Cancer
Cqvp
CNKI
Wanfang Data
More
....
Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by
Beijing Magtech Co.ltd
support@magtech.com.cn